Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04857515 · ClinicalTrials.gov registry record
Clinical Learning Study for a Mobile Smoking Cessation Program
A clinical trial, sponsored by Click Therapeutics.
- Completed
- Registry status
- 78
- Enrollment target
NCT04857515 is a clinical trial that has completed, run by Click Therapeutics. The registered enrollment target is 78 participants.
The verdict
NCT04857515 has completed, sponsored by Click Therapeutics.
- COMPLETED
- Registry status
- 78 participants
- Enrollment target
Study Summary
The purpose of this study are to obtain learnings regarding the Digital Therapeutic (DTx) experience of Clickotine, including acceptability and preference of the overall program and specific DTx components, as well as to obtain learnings related to adult participants' use of the DTx for smoking cessation.
Interventions
- DEVICE Clickotine®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2021-03-12 |
| Est. Completion | 2021-06-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04857515
The ClinicalTrials.gov registry entry for NCT04857515 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Click Therapeutics, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clickotine® is the first listed.
NCT04857515 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04857515 about?
NCT04857515 is a clinical study titled "Clinical Learning Study for a Mobile Smoking Cessation Program". The purpose of this study are to obtain learnings regarding the Digital Therapeutic (DTx) experience of Clickotine, including acceptability and preference of the overall program and specific DTx components, as well as to obtain learnings related to adult participants' use of the DTx for smoking cess...
What is the current status of trial NCT04857515?
This trial is currently completed. The enrollment target is 78 participants. The study started on 2021-03-12. Estimated completion is 2021-06-28.
What interventions are being tested in trial NCT04857515?
The interventions under investigation include: Clickotine® (DEVICE).
Who is sponsoring clinical trial NCT04857515?
This trial is sponsored by Click Therapeutics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.